Pieris Pharmaceuticals, Inc. CEO Stephen S. Yoder to Be Interviewed on “The Big Biz Show” on September 23rd at 3:50 pm EDT
NEW YORK, NY, Sep 23, 2015 – Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel bio-therapeutics through its proprietary Anticalin® technology platform, announced today that
September 23, 2015